Jessica Orf

Jessica Orf is a Principal Scientist II at Gilead Sciences, where she leads the Oncology in vivo pharmacology group. Jessica specializes in oncology mouse models. Her team supports in vivo pharmacology research across Gilead’s oncology pipeline, contributing to the development of diverse therapeutic modalities including small molecules, biologics, and cell therapies.